Gilero

Executive Summary

Gilero is a US-based contract development and manufacturing organization (CDMO) specializing in medical devices and drug delivery systems. Founded in 2002 and headquartered in Research Triangle Park, North Carolina, the company offers end-to-end services from concept and design through scalable commercial manufacturing. As part of the Sanner Group, Gilero leverages a global manufacturing network to serve healthcare clients worldwide. The CDMO market is growing due to outsourcing trends, and Gilero's integrated capabilities position it well to capture demand from medtech and pharma companies seeking regulatory expertise and production scale. However, as a private entity, its financial performance and growth trajectory are not publicly disclosed, limiting visibility. Gilero's strength lies in its partnership approach and the backing of Sanner Group, which provides access to international resources and quality systems. The company focuses on complex drug-device combinations, including injectables, inhalers, and wearable devices. While the CDMO sector faces competition from larger players, Gilero's niche in drug delivery and medical devices offers differentiation. Key risks include client concentration, regulatory changes, and supply chain disruptions. Overall, Gilero is a solid but unremarkable player in a fragmented market, with steady demand but limited near-term catalysts for outsized growth.

Upcoming Catalysts (preview)

• TBDNew contract wins in drug delivery systems40% success